Skip to main content
. 2017 Jan 5;26(5):932–941. doi: 10.1093/hmg/ddx008

Figure 6.

Figure 6

Restoration of SMN via ASO treatment corrects SMA spleen pathology. Representative images of spleen sections from PND 12 ASO-treated SMA mice (right), sham-treated SMA control (center), and WT control (left). (A) H&E staining, treated SMA spleen displays architecture and red pulp similar to WT. (B) Immunostaining for B lymphocytes using anti-B220. (C) Immunostaining for T lymphocytes using anti-CD3.